Whey and weight-loss drugs to eat into Applied Nutrition profit Retail Applied Nutrition has warned that a major jump in whey protein prices will eat into its bottom line next year even as it beefed up its forecasts for the next year. The protein-shake maker revealed its adjusted pre-tax profit had risen by more than 40 per cent in the 12 months to August, a figure [...]
Mounjaro and Wegovy demand helps Chemist4U sales double healthcare Increasing demand for weight-loss jabs such as Mounjaro and Wegovy has helped sales at the firm behind online pharmacy Chemist4U almost double. The Skelmersdale-based business has reported a turnover of £59.5m for the year to 30 September, 2024, according to new accounts filed with Companies House. The latest total comes after the firm behind Chemist4U [...]
Is your business about to feel the Ozempic squeeze? Opinion Reshaping stomachs with weightloss drugs like Ozempic likely means reshaping some markets (and probably your strategy), says Paul Armstrong Ozempic, Wegovy, and Mounjaro are driving a subtle but undeniable shift in obesity rates across the U.S, showing a 2 per cent drop so far. While it’s too soon to crown these drugs the cure-all, their [...]
Digital health firm explores London listing amid surge in demand for weight-loss jabs June 24, 2024 Digital health business Reset Health is mulling a potential listing on London's stock market as it looks to pounce on the boom in demand for weight-loss jabs.
Ozempic and Wegovy: What happens when a drug goes viral? May 18, 2024 Novo Nordisk's Wegovy and Ozempic have been heralded as the solution to the world's growing obesity problems. But when celebrities and influencers misuse them and start documenting their weight loss journeys online, should we take stock?